ZNF674 and thyroid gland carcinoma: The achievements of this exploration are consistent with other investigations that lncRNA ZNF674-AS1 is underexpressed in thyroid cancer, and overexpression of lncRNA ZNF674-AS1 can remarkably inhibit cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) [15].